Hematology Analyzer Financing for In-House CBCs

Same-Day Results, Zero Send-Outs

Running CBCs in-house means a result during the visit, not a callback tomorrow. You keep the reimbursement, cut Quest and LabCorp send-out fees, and make faster clinical decisions on anemia, infection, and medication monitoring.

Terms Matched to Test Volume

We build the payment around how many CBCs you actually run. A practice billing 85025 forty times a day carries the note easily, so we stretch the term to keep the monthly light against reagent and labor cost.

Application-Only up to $150,000

No tax returns or full financials for most requests under $150,000. A one-page application and a soft look usually return a same-day decision, so an XN-550 or DxH 560 can be installed in days, not weeks.

All Credit Profiles Considered

Newer practices and owners with challenged credit still get funded through our 500+ lender network. We shop the file instead of running it once, so a 640 score does not end the conversation.

The bench you choose drives the whole economics of in-house hematology, so we finance across the range. The Sysmex XN-550 is the workhorse for mid-volume primary care and urgent care: a single-module analyzer with fluorescence flow cytometry, a true 5-part differential, reticulocyte and NRBC reporting, and body-fluid mode. Smaller offices often prefer the Sysmex XN-450 or the older XN-L benchtops, while high-throughput groups step up to the XN-1000 with an SP-50 slidemaker stainer. On the Coulter side, the Beckman Coulter DxH 560 AL is a compact, closed-tube CBC analyzer that runs the classic Coulter impedance principle with a light reagent footprint, ideal for a two or three provider office. Larger labs run the DxH 690T or DxH 900.

All of these are CLIA moderate-complexity instruments, so financing usually includes the analyzer, middleware or an interface to your EHR, calibrators and controls such as Sysmex e-CHECK, the first reagent order, and a manufacturer service agreement. We also fund the LIS connection and barcode setup that let results flow straight into the chart. Whatever configuration your Sysmex or Beckman rep quotes, we can structure the whole package as one facility so you are not paying cash for install while financing only the box.

Recent hematology analyzer deals we placed for US practices. Details are representative of real structures we fund.

• $78,500, Sysmex XN-550, Charlotte NC primary care group. Three physicians, 9 years in practice, 712 owner credit. Approved at 5.74% APR over 60 months, $0 down, with the term matched to roughly 45 CBCs a day. This is the deal that anchors our in-house pitch: the monthly ran under their prior Quest send-out spend.
• $52,000, Beckman Coulter DxH 560 AL, solo family medicine, Columbus OH. Six years in practice, 688 credit. Structured at 6.34% APR over 48 months with 10 percent down. Application-only, funded in two days.
• $132,000, Sysmex XN-1000 with SP-50 slidemaker, urgent care group, Tampa FL. Four years in practice, 705 credit. Approved at 5.99% APR over 66 months, $0 down, reagents and service wrapped in.
• $61,000, Sysmex XN-450, community internal medicine, Albuquerque NM. Fifteen years in practice, 740 credit. Best-in-class 5.49% APR over 60 months, $0 down.

Rates shown reflect the specific credit and term of each file. Your rate starts from 5.49% APR for qualified practices and is quoted after a soft review.

The case for owning an analyzer is simple arithmetic. Medicare reimburses CPT 85025 (complete CBC with automated differential) at roughly $10 to $11, and commercial payers pay more. A practice running 40 CBCs a day, about 850 a month, that was previously sending those specimens to a reference lab is capturing $8,500 or more in monthly reimbursement it used to give away, minus reagent and control cost that typically runs a few dollars per test. On an XN-550 financed near $1,490 a month, the instrument covers itself many times over and turns cash-flow positive quickly.

Then there is the tax side. Under Section 179, a practice can deduct the full purchase price of qualifying diagnostic equipment in the year it is placed in service, up to the annual cap (about $2.5 million in 2026), rather than depreciating it over five years. 100 percent bonus depreciation is also available on equipment placed in service, which can apply on top for amounts above the Section 179 limit. On a $78,500 analyzer, a practice in a 32 percent bracket can see north of $25,000 in first-year tax savings while paying for the machine on a multi-year note. Financing plus Section 179 is the combination most CPAs recommend: you keep your cash, deduct the whole cost now, and let the reimbursement stream service the payment. Confirm specifics with your accountant, since limits and phase-outs change.

Brobas Capital Partners is a medical equipment finance broker, not a single lender, so we shop your request across a network of more than 500 US funding sources. That structure is why we can approve files a bank turns down. Established practices, newer groups under three years old, and owners with challenged credit all have a path here, because we place each deal with the lender that fits the profile instead of forcing one box.

For requests up to $150,000, the process is application-only: a short one-page application and a soft credit look, usually with a same-day decision and no tax returns or financial statements. Above $150,000 we may ask for two years of returns and recent bank statements, still with fast turnaround. Once approved, funds go to your Sysmex or Beckman vendor within 24 to 72 hours so installation can be scheduled that week.

Structures include $0 down, deferred first payments for 60 or 90 days while the analyzer ramps, fair-market-value leases, and dollar-buyout agreements that let you own the instrument at term. Tell us the model you are quoting and your monthly CBC volume, and we will come back with a payment built around your practice, from 5.49% APR for qualified borrowers. Rates are never guaranteed and are set after review.

What does it cost to finance a Sysmex XN-550?

A new XN-550 typically runs $60,000 to $90,000 depending on middleware and reticulocyte options. Financed from 5.49% APR over 60 months, a $78,000 system lands near $1,490 a month for a qualified practice, well under what most groups bill in in-house CBCs monthly. Exact rate depends on credit, time in practice, and term.

Can I finance a used or refurbished analyzer?

Yes. We fund refurbished Beckman Coulter DxH 560 and Sysmex units from certified resellers, often at 30 to 45 percent below new. Terms are usually a bit shorter, but the same application-only path applies under $150,000.

Do you finance reagents and the service contract?

We can wrap installation, middleware, the first reagent stock, and a Sysmex or Beckman service agreement into the amount financed so your cash outlay at go-live is close to zero. Consumables billed on a recurring basis are handled separately.

My practice is only two years old. Can I still qualify?

Yes. We regularly fund practices under three years old. Time in practice affects the rate and structure, not whether you get approved, and our lender network includes several who specialize in newer medical entities.

How fast can the analyzer be installed?

Most application-only approvals come back the same day. Once you sign, funding to the vendor is typically 24 to 72 hours, so a Sysmex or Beckman rep can schedule install that week.